MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 137 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $3,000 | -99.6% | 2,863 | -98.7% | 0.00% | – |
| Q1 2017 | $697,000 | -33.0% | 226,376 | -11.2% | 0.00% | – |
| Q4 2016 | $1,040,000 | -29.8% | 255,000 | +9.2% | 0.00% | – |
| Q3 2016 | $1,482,000 | +8.8% | 233,464 | -7.6% | 0.00% | – |
| Q2 2016 | $1,362,000 | -50.6% | 252,719 | -23.2% | 0.00% | -100.0% |
| Q1 2016 | $2,756,000 | +5.9% | 329,234 | -0.0% | 0.00% | 0.0% |
| Q4 2015 | $2,603,000 | -14.6% | 329,356 | -8.0% | 0.00% | 0.0% |
| Q3 2015 | $3,047,000 | -2.4% | 358,098 | +41.9% | 0.00% | 0.0% |
| Q2 2015 | $3,121,000 | -0.3% | 252,414 | -4.2% | 0.00% | 0.0% |
| Q1 2015 | $3,131,000 | +5.5% | 263,489 | +0.3% | 0.00% | 0.0% |
| Q4 2014 | $2,968,000 | -1.7% | 262,639 | -23.6% | 0.00% | 0.0% |
| Q3 2014 | $3,019,000 | +17.9% | 343,880 | -2.1% | 0.00% | 0.0% |
| Q2 2014 | $2,561,000 | +35.4% | 351,105 | -6.4% | 0.00% | 0.0% |
| Q1 2014 | $1,891,000 | +3.7% | 375,080 | +9.6% | 0.00% | 0.0% |
| Q4 2013 | $1,824,000 | +22.9% | 342,180 | -12.6% | 0.00% | – |
| Q3 2013 | $1,484,000 | -37.2% | 391,356 | +11.6% | 0.00% | -100.0% |
| Q2 2013 | $2,363,000 | – | 350,728 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|